Pharmaxis Ltd News

Pharmaxis Ltd: Syntara Receives $5m R&D Tax Incentive

Dec 5, 2023 08:26

Pharmaxis Ltd: Change of Company Name

Dec 4, 2023 09:59

Pharmaxis Ltd: Change of Director's Interest Notice - GP

Nov 29, 2023 07:43

Pharmaxis Ltd: Notification regarding unquoted securities - PXS

Nov 29, 2023 07:39

Pharmaxis Ltd: Results of Meeting

Nov 28, 2023 09:50

Pharmaxis Ltd: CEO Presentation to AGM

Nov 28, 2023 07:47

Pharmaxis Ltd: Chair's Address to Shareholders

Nov 28, 2023 07:40

Pharmaxis Ltd: Application for quotation of securities - PXS

Nov 13, 2023 09:41

Pharmaxis Ltd: First patient dosed in Phase 2 trial of sleep disorder

Nov 9, 2023 06:28

Pharmaxis Ltd: Application for quotation of securities - PXS

Nov 6, 2023 09:44

Pharmaxis Ltd: Investor presentation - quarterly update

Oct 31, 2023 06:46

Pharmaxis Ltd: Quarterly Activities Report

Oct 31, 2023 05:47

Pharmaxis Ltd: Quarterly Appendix 4C Cash Flow Report

Oct 31, 2023 05:24

Pharmaxis Ltd: PXS Quarterly Shareholder Update and Investor Call

Oct 30, 2023 07:59

Pharmaxis Ltd: Appendix 4G

Oct 26, 2023 14:10

Pharmaxis Ltd: Corporate Governance Statement

Oct 26, 2023 14:10

Pharmaxis Ltd: Annual Report to shareholders

Oct 26, 2023 14:09

Pharmaxis Ltd: Notice of Annual General Meeting/Proxy Form

Oct 26, 2023 14:05

Pharmaxis Ltd: Pharmaxis Completes Sale of Mannitol Business

Oct 19, 2023 05:19

Pharmaxis Ltd: Investor Presentation

Oct 17, 2023 07:31